Central Sensitization, a foundational mechanism to learning and memory, is a confounding factor in the diagnosis and treatment of MFTPs. Central Sensitization is “ defined as a state in which the central nervous system amplifies sensory input across many organ systems”([Source)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422459/#:~:text=Central sensitization can be defined,increases sensitivity for future stimulation.) and explains why pain can persist without injury. Their research delves into the three pathways that lead to the creation of myofascial trigger points. Understanding these pathways, pave the way for effective treatment strategies.
The Role of
Central Sensitization
The Dynamic Duo: Insights into Myofascial Pain Syndrome and Central Sensitization with
Dr. Shah and Dr. Srbely
Myofascial Pain Syndrome is a common medical condition that affects millions of individuals worldwide. Approximately 95% of individuals with chronic pain disorders are affected by Myofascial Pain Syndrome. These are staggering numbers, however, despite their prevalence, Myofascial Pain Syndrome presents a diverse array of manifestations and sources, hence making the diagnosis and treatment a challenge. Dr. Jay Shah and Dr. John Srbely’s refreshing research presents a groundbreaking direction toward understanding the pathophysiology, clinical manifestations, and management of Myofascial Pain Syndrome. Their joint research provides valuable insights and a unique perspective on this complex topic.
The Dynamic Duo: Who are Dr. Jay Shah and Dr. John Srbely?
Dr. Shah’s work delves into the functional anatomy of myofascial trigger points, explaining how they can lead to sensitization and persistent pain. For those interested in this space, they discuss this in detail during a recent <interview>. They discuss the concept of somatovisceral and viscerosomatic interaction, where pain can be referred from muscles to viscera and vice versa. Additionally, Dr. Srbley expands on the concept of neurogenic inflammation, an “inflammation that is produced through the release of substances from the nervous system—in particular, from small-diameter primary afferent fibers”(source) and highlights its contribution to the pathophysiology of myofascial pain even in the absence of injury.
Understanding the Pathophysiology
Dr. Shah’s work delves into the functional anatomy of myofascial trigger points, explaining how they can lead to sensitization and persistent pain. For those interested in this space, they discuss this in detail during a recent <interview>. They discuss the concept of somatovisceral and viscerosomatic interaction, where pain can be referred from muscles to viscera and vice versa. Additionally, Dr. Srbley expands on the concept of neurogenic inflammation, an “inflammation that is produced through the release of substances from the nervous system—in particular, from small-diameter primary afferent fibers”(source) and highlights its contribution to the pathophysiology of myofascial pain even in the absence of injury.
The Dynamic Duo: Insights into Myofascial Pain Syndrome and Central Sensitization with Dr. Shah and
Dr. Srbely
Myofascial Pain Syndrome is a common medical condition that affects millions of individuals worldwide. Approximately 95% of individuals with chronic pain disorders are affected by Myofascial Pain Syndrome. These are staggering numbers, however, despite their prevalence, Myofascial Pain Syndrome presents a diverse array of manifestations and sources, hence making the diagnosis and treatment a challenge. Dr. Jay Shah and Dr. John Srbely’s refreshing research presents a groundbreaking direction toward understanding the pathophysiology, clinical manifestations, and management of Myofascial Pain Syndrome. Their joint research provides valuable insights and a unique perspective on this complex topic.
The Dynamic Duo: Who are
Dr. Jay Shah and Dr. John Srbely?
Dr. Shah’s work delves into the functional anatomy of myofascial trigger points, explaining how they can lead to sensitization and persistent pain. For those interested in this space, they discuss this in detail during a recent <interview>. They discuss the concept of somatovisceral and viscerosomatic interaction, where pain can be referred from muscles to viscera and vice versa. Additionally, Dr. Srbley expands on the concept of neurogenic inflammation, an “inflammation that is produced through the release of substances from the nervous system—in particular, from small-diameter primary afferent fibers”(source) and highlights its contribution to the pathophysiology of myofascial pain even in the absence of injury.
Understanding the Pathophysiology
Understanding the complex role central sensitization plays in MPS creates an avenue for patients and providers to better understand the cause of pain and hence can bring light to experiences that are often only understood through subjective expressions which in turn can be difficult to communicate and understand.
If you want to learn more about the current trends and developments in Myofascial Pain Syndrome’s diagnosis and treatment, we invite you to join the PREMUS, WDPI, and MYOPAIN 2023 which features Dr. Shah and Dr. Srbley will present their work along with some of the best and brightest minds in scientific research, ergonomics, and occupational health! Register now at premus2023.com and be a part of the next generation of healthcare.
Understanding the root cause, and creating personalized care plans is the hallmark of the approach advocated by Dr. Shah and Dr. Srbely. They stress the need for comprehensive physical examination and palpation of muscles to identify active trigger points and signs of allodynia and hyperalgesia. They suggest that treatments like [...] electrical stimulation and acupuncture can make a big difference for patients. Their approach stands out because it moves away from relying solely on medication. While drugs have been a key part of treating this type of pain, exploring non-drug treatments can offer new ways to help patients live better lives without the drawbacks of traditional approaches.
Comprehensive Management
Approaches
Dr. Shah and Dr. Srbley present exciting new horizons for the diagnosis and treatment of Myofascial Pain Syndrome. They bring home the idea that pain doesn’t operate in absolutes. They demonstrate that pain doesn’t belong only to the brain or only to the body but actually qualify the role that Central Sensitization plays in Myofascial Pain Syndrome. Understanding the complex role central sensitization plays in Myofascial Pain Syndrome creates an avenue for patients and providers to better understand the cause of pain and hence can bring light to experiences that are often only understood through subjective expressions which in turn can be difficult to communicate and understand. That fundamentally changes how one approaches understanding and redressing chronic pain. We had a chance to speak to the two of them about their research in a recent <interview>. The interview offers a wealth of knowledge to anyone interested in understanding myofascial pain and trigger points. Here are a few insights covered in the podcast:
-
Is it possible for trigger points to develop with no injury?
-
How is the perception of trigger points influenced by changes in the usual pattern and direction of somatovisceral and viscerosomatic information flows?
-
What causes pain even after the successful treatment of a condition? How can an understanding of Central Sensitization improve the treatment of chronic pain?
For medical professionals, researchers, and individuals who suffer from myofascial pain and trigger points, this interview offers a wealth of valuable information. It serves as a valuable resource for gaining a deeper understanding of the condition and offers insights that can contribute to improved patient care and outcomes. Head over to our <exclusive interview> with Dr. Shah and Dr. Srbely hosted by Vivek Narayan to soothe your curiosity.